NUCKS Is a Positive Transcriptional Regulator of Insulin Signaling

•NUCKS levels inversely correlate with obesity in humans and mice•NUCKS knockout mice show reduced insulin signaling, glucose intolerance, and obesity•NUCKS positively regulates the IR promoter through chromatin alterations•NUCKS is a molecular link between energy/glucose homeostasis and transcription

SummaryAlthough much is known about the molecular players in insulin signaling, there is scant information about transcriptional regulation of its key components. We now find that NUCKS is a transcriptional regulator of the insulin signaling components, including the insulin receptor (IR). Knockdown of NUCKS leads to impaired insulin signaling in endocrine cells. NUCKS knockout mice exhibit decreased insulin signaling and increased body weight/fat mass along with impaired glucose tolerance and reduced insulin sensitivity, all of which are further exacerbated by a high-fat diet (HFD). Genome-wide ChIP-seq identifies metabolism and insulin signaling as NUCKS targets. Importantly, NUCKS is downregulated in individuals with a high body mass index and in HFD-fed mice, and conversely, its levels increase upon starvation. Altogether, NUCKS is a physiological regulator of energy homeostasis and glucose metabolism that works by regulating chromatin accessibility and RNA polymerase II recruitment to the promoters of IR and other insulin pathway modulators.

Graphical AbstractFigure optionsDownload full-size imageDownload as PowerPoint slide